Investors
Information Disclosure
-
2022 INTERIM REPORT2022.09.26
-
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS2022.09.26
-
VOLUNTARY ANNOUNCEMENT - CATEGORY I INNOVATIVE MEDICINE "TDI01" OBTAINED APPROVAL FOR COVID-19 CLINICAL TRIAL2022.09.26
-
VOLUNTARY ANNOUNCEMENT SHARE - PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.09.23
-
VOLUNTARY ANNOUNCEMENT - ENTERING INTO LICENSE AGREEMENT2022.09.22
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.09.20
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.09.19
-
NEXT DAY DISCLOSURE RETURN2022.09.16